INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 2 filers reported holding INSMED INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,913,750 | +239.1% | 155,000 | +183.4% | 0.04% | +214.3% |
| Q2 2023 | $1,154,170 | +459.4% | 54,700 | +352.1% | 0.01% | +600.0% |
| Q1 2023 | $206,305 | -85.0% | 12,100 | -82.4% | 0.00% | -85.7% |
| Q4 2022 | $1,376,622 | +9.3% | 68,900 | +17.8% | 0.01% | 0.0% |
| Q3 2022 | $1,260,000 | +1066.7% | 58,500 | +963.6% | 0.01% | +1300.0% |
| Q2 2022 | $108,000 | +191.9% | 5,500 | +243.8% | 0.00% | – |
| Q1 2022 | $37,000 | -14.0% | 1,600 | 0.0% | 0.00% | – |
| Q4 2021 | $43,000 | -49.4% | 1,600 | -36.0% | 0.00% | -100.0% |
| Q1 2021 | $85,000 | -88.2% | 2,500 | -88.4% | 0.00% | -80.0% |
| Q4 2020 | $719,000 | -68.5% | 21,600 | -77.4% | 0.01% | -81.5% |
| Q4 2019 | $2,280,000 | +159.1% | 95,504 | +91.4% | 0.03% | +145.5% |
| Q3 2019 | $880,000 | +224.7% | 49,900 | +370.8% | 0.01% | +266.7% |
| Q2 2019 | $271,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
| Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
| Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
| Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
| NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
| Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
| Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
| Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
| Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
| EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |